Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Carlson

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Lancet. Oncology|August 31, 2016
HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort studyJason W D Hearn, Ghada AbuAli, Chad A Reichard, et al.
American Journal of Respiratory Cell and Molecular Biology|September 24, 2019
Nontuberculous Mycobacteria Show Differential Infectivity and Use Phospholipids to Antagonize LL-37Jennifer R Honda, Tamara Hess, Rachel Carlson, et al.
The Journal of Urology|June 18, 2013
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient populationR Jeffrey Karnes, Eric J Bergstralh, Elai Davicioni, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Lancet. Oncology|August 31, 2016
HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort studyJason W D Hearn, Ghada AbuAli, Chad A Reichard, et al.
American Journal of Respiratory Cell and Molecular Biology|September 24, 2019
Nontuberculous Mycobacteria Show Differential Infectivity and Use Phospholipids to Antagonize LL-37Jennifer R Honda, Tamara Hess, Rachel Carlson, et al.
The Journal of Urology|June 18, 2013
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient populationR Jeffrey Karnes, Eric J Bergstralh, Elai Davicioni, et al.
Pageof 2